Sanford-Burnham and Daiichi Sankyo Partnership (IMAGE)
Caption
The goal of the partnership is to develop first-in-class therapeutics for the treatment of cardiovascular-metabolic diseases.
Credit
Sanford-Burnham Medical Research Institute
Usage Restrictions
None
License
Licensed content